Literature DB >> 15982390

Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients.

Yah-Yuen Tan1, Yang-Guo Fan, Ying Lu, Shelley Hwang, Cheryl Ewing, Laura Esserman, Eugene Morita, Patrick Treseler, Stanley P L Leong.   

Abstract

Selective sentinel lymphadenectomy (SSL) has replaced axillary lymph node dissection (ALND) for many patients with early breast cancer and negative sentinel lymph nodes (SLNs). Yet many patients with a positive SLN are undergoing unnecessary ALND, as no further disease is found in the axilla. The aim of our study was to determine factors associated with additional positive lymph nodes in the axilla in patients who have a positive SLN. This was a retrospective study of patients undergoing SSL with ALND as part of their treatment for breast cancer at a single institution from November 1997 to August 2003. Only patients with one or more positive SLNs were selected for this study. There were 86 patients who fit our study criteria. Of these, 38% had further positive lymph nodes upon ALND. More than one positive SLN and a ratio of positive SLNs to total SLNs of greater than 0.5 were found to be predictors for additional axillary nodal involvement in both univariate and multivariate analyses. The number of positive SLNs and the ratio of positive SLNs to total SLNs is an indication of total tumor burden in the sentinel nodes and may be a reflection of the propensity of the tumor for further lymphatic invasion in the axillary basin.

Entities:  

Mesh:

Year:  2005        PMID: 15982390     DOI: 10.1111/j.1075-122X.2005.21633.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  5 in total

1.  Comparison of two models for predicting non-sentinel lymph node metastases in sentinel lymph node-positive breast cancer patients.

Authors:  Giovanni D'Eredita'; Vito Leopoldo Troilo; Fernando Fischetti; Giuseppe Rubini; Tommaso Berardi
Journal:  Updates Surg       Date:  2011-05-31

2.  Sentinel node biopsy for breast cancer patients: issues for discussion and our practice.

Authors:  Georgios Pechlivanides; Dorothy Vassilaros; Anastasios Tsimpanis; Anastasia Apostolopoulou; Stamatis Vasilaros
Journal:  Patholog Res Int       Date:  2010-12-28

3.  Issues related to sentinel lymph node assessment in the management of breast cancer-what are relevant in pathology reports?

Authors:  Patricia Tai; Kurian J Joseph; Edward Yu
Journal:  Patholog Res Int       Date:  2011-03-15

4.  A novel nomogram for decision-making assistance on exemption of axillary lymph node dissection in T1-2 breast cancer with only one sentinel lymph node metastasis.

Authors:  Lei Liu; Yaoxin Lin; Guozheng Li; Lei Zhang; Xin Zhang; Jiale Wu; Xinheng Wang; Yumei Yang; Shouping Xu
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

5.  The prognostic value of lymph node cross-sectional cancer area in node-positive breast cancer: a comparison with N stage and lymph node ratio.

Authors:  Yanxia Li; Earle Holmes; Karan Shah; Kevin Albuquerque; Anna Szpaderska; Cağatay Erşahin
Journal:  Patholog Res Int       Date:  2012-10-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.